FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Thank You!

Thanks for letting us know your contact information is up-to-date. We can’t wait to share with you the groundbreaking progress we’ve been making — stay tuned!